Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model
- 30 June 2005
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 83 (6), 1665-1673
- https://doi.org/10.1016/j.fertnstert.2004.11.068
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effect of tumor necrosis factor-α blocker (infliximab) on blastocyst development in vitroFertility and Sterility, 2004
- New medical treatments for endometriosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Efficacy and safety of the fully human anti-tumour necrosis factor monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II studyAnnals Of The Rheumatic Diseases, 2003
- Endometriosis is sustained by tumour necrosis factor-αMedical Hypotheses, 2003
- Relationship between seminal plasma interleukin-6 and tumor necrosis factor α levels with semen parameters in fertile and infertile menUrological Research, 2002
- Levels of interferon-Γ and tumor necrosis factor-α in sera and cervical mucus of fertile and infertile women: implication in infertilityJournal of Reproductive Immunology, 1995
- Effect of Cytokines on Sperm Motility and Ionophore—Stimulated Acrosome ReactionArchives of Andrology, 1995
- Physiological relevance of tumor necrosis factor in mediating macrophage-Leydig cell interactions.Endocrinology, 1994
- Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosisAmerican Journal of Obstetrics and Gynecology, 1992
- The Testicular Effects of Tumor Necrosis FactorAnnals of Surgery, 1990